Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chiba, 260-8675 Japan.
Plant Cell Physiol. 2013 May;54(5):686-96. doi: 10.1093/pcp/pct040. Epub 2013 Mar 15.
The Rubiaceae species, Ophiorrhiza pumila, accumulates camptothecin, an anti-cancer alkaloid with a potent DNA topoisomerase I inhibitory activity, as well as anthraquinones that are derived from the combination of the isochorismate and hemiterpenoid pathways. The biosynthesis of these secondary products is active in O. pumila hairy roots yet very low in cell suspension culture. Deep transcriptome analysis was conducted in O. pumila hairy roots and cell suspension cultures using the Illumina platform, yielding a total of 2 Gb of sequence for each sample. We generated a hybrid transcriptome assembly of O. pumila using the Illumina-derived short read sequences and conventional Sanger-derived expressed sequence tag clones derived from a full-length cDNA library constructed using RNA from hairy roots. Among 35,608 non-redundant unigenes, 3,649 were preferentially expressed in hairy roots compared with cell suspension culture. Candidate genes involved in the biosynthetic pathway for the monoterpenoid indole alkaloid camptothecin were identified; specifically, genes involved in post-strictosamide biosynthetic events and genes involved in the biosynthesis of anthraquinones and chlorogenic acid. Untargeted metabolomic analysis by Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) indicated that most of the proposed intermediates in the camptothecin biosynthetic pathway accumulated in hairy roots in a preferential manner compared with cell suspension culture. In addition, a number of anthraquinones and chlorogenic acid preferentially accumulated in hairy roots compared with cell suspension culture. These results suggest that deep transcriptome and metabolome data sets can facilitate the identification of genes and intermediates involved in the biosynthesis of secondary products including camptothecin in O. pumila.
茜草科植物纤细钩吻积累了喜树碱,一种具有强大 DNA 拓扑异构酶 I 抑制活性的抗癌生物碱,以及蒽醌,它们是异查尔酮和半萜烯途径结合的产物。这些次生产物的生物合成在纤细钩吻发根中很活跃,但在细胞悬浮培养中非常低。利用 Illumina 平台对纤细钩吻发根和细胞悬浮培养物进行了深度转录组分析,每个样本共产生 20 亿个序列。我们使用 Illumina 衍生的短读序列和传统的 Sanger 衍生的表达序列标签克隆构建了一个混合转录组组装,该文库是使用发根 RNA 构建的全长 cDNA 文库。在 35608 个非冗余的 unigenes 中,有 3649 个在发根中比在细胞悬浮培养中优先表达。鉴定了参与单萜吲哚生物碱喜树碱生物合成途径的候选基因;具体来说,鉴定了涉及后链格酰胺生物合成事件的基因和参与蒽醌和绿原酸生物合成的基因。傅里叶变换离子回旋共振质谱(FT-ICR-MS)的非靶向代谢组学分析表明,与细胞悬浮培养相比,喜树碱生物合成途径中大多数推测的中间产物在发根中优先积累。此外,与细胞悬浮培养相比,一些蒽醌和绿原酸在发根中优先积累。这些结果表明,深度转录组和代谢组数据集可以促进鉴定参与次生产物生物合成的基因和中间产物,包括纤细钩吻中的喜树碱。